Back to Search
DONALD NORTHFELT, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1316922008IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
54262(CO)59022(CA)30026(AZ)
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 1985
Research & Publications (20)
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
PMID 19468757·Support Care Cancer·2010
4-observational
Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
PMID 19142669·Support Care Cancer·2009
3-trial
Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man.
PMID 18347564·Clin Adv Hematol Oncol·2008
5-case
Live, attenuated varicella zoster vaccination of an immunocompromised patient.
PMID 18286341·J Gen Intern Med·2008
5-case
Trastuzumab-induced cardiotoxicity: heart failure at the crossroads.
PMID 18241629·Mayo Clin Proc·2008
6-review
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
PMID 18224661·Cancer·2008
3-trial
Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma.
PMID 18019833·Int J Nanomedicine·2007
6-review
Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
PMID 17409917·J Thorac Oncol·2006
8-other
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
PMID 16730134·Int J Radiat Oncol Biol Phys·2006
3-trial
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer.
PMID 16311275·Ann Oncol·2006
3-trial
The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer.
PMID 16029804·Int J Radiat Oncol Biol Phys·2005
3-trial
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
PMID 15150304·J Natl Cancer Inst·2004
3-trial
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.
PMID 14518696·Antivir Ther·2003
3-trial
A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer.
PMID 12799626·Br J Cancer·2003
3-trial
A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
PMID 12467070·Cancer·2002
3-trial
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.
PMID 12007754·J Pain Symptom Manage·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5777 E MAYO BLVD
PHOENIX, AZ 85054 - Phone
- (480) 301-8000
Quick Facts
- NPI
- 1316922008
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile